Despite meaningful progress in the identification of risk factors and the development of highly effective prevention tools, the residual risk of cardiovascular events remains high (about 60-70% in the major outcome trials dealing with statins). Awareness of this problem can properly orient the search for new effective and efficient preventive strategies.
|Journal||Giornale Italiano di Cardiologia|
|Issue number||4 SUPPL.1|
|Publication status||Published - Apr 2008|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine